Friday, November 6, 2020 | 6:00 PM EST
Supported by an educational grant from Gilead Sciences
Session Description:
Join this lively discussion of the latest RA treatment trends, tips for patient-centered care, and expert insights on pivotal trials and the newest data.
- Hear expert perspectives on how to manage RA after DMARD failure
- Get the latest perspectives on JAK inhibitors
- Help understand the importance of your patients’ preferences and expectations for managing their RA
Attendees must be registered for the ACR Convergence to participate.
This is not an official program of the American College of Rheumatology.
Session Speakers:
Stanley B. Cohen, MD
Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Co-Medical Director
Metroplex Clinical Research Center
Dallas, Texas
Sheetal Desai, MD, MSEd
Chief of Rheumatology, Interim
Rheumatology Fellowship Program Director
Director, Lupus Clinic
Associate Clinical Professor of Medicine
Division of Rheumatology
University of California, Irvine
Irvine, California
Eric Ruderman, MD
Professor
Northwestern University Feinberg School of Medicine
Clinical Practice Director
Northwestern Medical Group
Chicago, Illinois
Resources:
Email Contact Information: [email protected]